Endpoints News 生物医药· ENDPOINTS·· 22 天前AI 评分32
Genmab 因癌症数据股价上涨,Iovance、Coherus 下跌
Genmab's stock rises on cancer data, while Iovance, Coherus tumble
AI 导读
Genmab 因癌症数据股价上涨,Iovance、Coherus 股价下跌。过去24小时,癌症试验消息推动多只股票双向波动,原文称将汇总关键结果,但全文需订阅阅读。
正文
Cancer trial news drove a number of stock moves in both directions over the past 24 hours. Here’s a summary of key results and their …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news